Kestra Advisory Services, LLC Intellia Therapeutics, Inc. Transaction History

Kestra Advisory Services, LLC

  • $17.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
SELL
$58.27 - $118.99 $112,111 - $228,936
-1,924 Closed
0 $0
Q4 2021

Jan 20, 2022
BUY
$100.76 - $138.36 $2,418 - $3,320
24 Added 1.26%
1,924 $227,000
Q3 2021

Oct 19, 2021
SELL
$132.37 - $176.78 $16,943 - $22,627
-128 Reduced 6.31%
1,900 $254,000
Q2 2021

Jul 28, 2021
BUY
$60.88 - $161.91 $123,464 - $328,353
2,028 New
2,028 $328,000

Others Institutions Holding NTLA

# of Institutions
326
Shares Held
88.8M
Call Options Held
673K
Put Options Held
865K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.6B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email